Long-term teduglutide associated with reduced parenteral nutrition/IV support

  • November 14, 2013

SAN DIEGO — Extended treatment with teduglutide resulted in significantly lower parenteral nutrition and/or intravenous fluid volume requirements among patients with intestinal failure associated with short bowel syndrome, a speaker said here.

“Teduglutide on a daily basis reduces their TPN [total parenteral nutrition] and IV fluid requirements by enhancing intestinal absorption,” Lauren K. Schwartz, MD, of the division of gastroenterology at Mount Sinai School of Medicine, said during the American College of Gastroenterology Annual Scientific Meeting. “Use of this drug actually reduces their diarrheal symptoms, improves their enteral tolerance and ultimately reduces their need for supplemental fluid.”

More »

Additional headlines from American College of Gastroenterology 2013 Annual Scientific Meeting

See All »